Immune Bowel Disease (including Crohn's disease and Ulcerative colitis). research hub

Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients with Active Crohn’s Disease or Ulcerative Colitis

This study looks at a new way to give Remsima, a medicine for Crohn's disease and ulcerative colitis, as a simple injection under the skin. We want to see how well it works, how safe it is, and how much medicine stays in the body.